Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma

CONTEMPORARY ISSUES IN COLORECTAL SURGICAL PRACTICE

132 p | 57 | 7

A simple and available measurement of oncosEV dsDNA to protein ratio as a potential tumor marker

9 p | 4 | 2

Robust expression of tumor suppressor miRNA’s let-7 and miR-195 detected in plasma of Saudi female breast cancer patients

10 p | 14 | 2

Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy

12 p | 8 | 1

Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing

11 p | 13 | 1

High-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence staining

13 p | 17 | 1

A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape

21 p | 3 | 1

Data mining of digitized health records in a resource-constrained setting reveals that timely immunophenotyping is associated with improved breast cancer outcomes

10 p | 6 | 0